The National Organization for Rare Disorders (NORDⓇ), Critical Path Institute (C-Path), and the US Food and Drug Administration (FDA) present a special webinar on the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), a collaborative project with C-Path, NORD, and the FDA. RDCA-DAP is an integrated database and analytics hub that is designed to be used in building novel tools to accelerate drug development across rare diseases.
This webinar explores why your organization should contribute to the RDCA-DAP, how to submit data to the platform, and how you can access and use the data and analytics platform. NORD, C-Path, and FDA will be available to answer specific questions about the project.
